C. Mohan et al., ACCUMULATION OF SPLENIC B1A CELLS WITH POTENT ANTIGEN-PRESENTING CAPABILITY IN NZM2410 LUPUS-PRONE MICE, Arthritis and rheumatism, 41(9), 1998, pp. 1652-1662
Objective. In order to shed light on the role of splenic B1 cells in d
isease pathogenesis in lupus-prone mice, this study was undertaken to
determine how efficiently these cells can serve as antigen-presenting
cells (LPC) and to ascertain which murine lupus susceptibility loci di
ctate the expansion of these cells. Methods. Spleens and peritoneal ca
vities (PerC) of NZM2410 lupus-prone mice, as well as of control B6 an
d New Zealand white mice, were examined for the prevalence, surface ph
enotype, and possible anatomic location of B1 cells. The antigen-prese
nting ability of fluorescence-sorted splenic B1a cells was assessed. L
evels of B1 cells were examined in B6 mice congenic for 4 different lu
pus susceptibility intervals. Results. NZM2410 lupus mice showed an ex
pansion of splenic and PerC B1a cells at all ages. These cells express
ed high levels of B71, B72, CD24, lymphocyte function-associated antig
en 1, and intercellular adhesion molecule 1, and had the functional ca
pability to serve as APC, Among the lupus susceptibility intervals stu
died, Sle2, but not Sle1, Sle3, or the H2 locus, affected the expansio
n of B1 cells. Conclusion. These findings raise the possibility that t
he genetically determined expansion of splenic B1a cells in lupus-pron
e mice might contribute to disease pathogenesis by augmenting the pres
entation of autoantigens to pathogenic T cells.